Not Tagged
adaptive biotechnology
['cll', 'adaptive ']
multiple #ash2022 presentations will reinforce clonoseq s ability to provide valuable insights for treatment surveillance &amp; clinical decision making. clonoseq is fda-cleared to assess mrd in cll, mm and b-all. for further info: 
Adaptive Biotechnologies is a pioneer & leader in immune-driven medicine. We aim to improve lives by learning from the wisdom of our adaptive immune systems.